相关实验视频
Updated: Jun 27, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
6.9K
多分子形揭示了皮肤T细胞淋巴瘤中对免疫疗法的内源性和瘤反应
David R Glass1, Koshlan Mayer-Blackwell1, Nirasha Ramchurren2
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Cell reports. Medicine
|April 26, 2024
概括
皮肤T细胞淋巴瘤 (CTCL) 的免疫疗法显示T细胞激活有限. 抗PD-1疗法增加了特定的T细胞类型,为这些皮肤癌的治疗反应提供了见解.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 皮肤T细胞淋巴瘤 (CTCL) 是一种具有不良预后的侵袭性皮肤癌.
- 目前的免疫疗法具有有限的疗效,它们在CTCL患者的免疫效应仍然不太清楚.
研究的目的:
- 在接受抗PD-1和/或干扰素- (IFN-γ) 治疗的CTCL患者中系统地描述局部,细胞和全身免疫反应.
- 识别与治疗反应或不反应相关的免疫特征.
主要方法:
- 利用高维技术对CTCL患者样本进行多原子分析.
- 应用了公正的方法来分析免疫细胞群和免疫治疗后的分子变化.
主要成果:
- 新生态T细胞在免疫治疗后没有显著的激活.
- IFN-γ诱导了最小的内源性免疫反应,而抗PD-1疗法增加了CLA+CD39+T细胞.
- 鉴定出了不同的免疫模块,其中激活的调节性CLA+CD39+T细胞丰富于非响应者和激活的细胞毒性CLA+CD39+T细胞在白血病CTCL患者中.
结论:
- 这项研究为CTCL免疫疗法的免疫学影响提供了关键的见解.
- 开发了一个可通用的多原子框架,用于分析癌症免疫治疗中的临床试验数据.
- 确定了特定的T细胞子集,这些T细胞可以作为预测CTCL治疗结果的生物标志物.
更多相关视频
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
4.9K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
相关概念视频
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Cytotoxic T Cells-mediated Immune Response
903
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
903